Four Analyses of Data for REBYOTA™ (fecal microbiota, live – jslm), the First FDA-Approved Microbiome-Based Treatment for the Prevention of Recurrent C. difficile Infection, Presented at DDW 2023

[ad_1] This section is Partnership Content supplied The content in this section is supplied by Business Wire for the purposes of distributing press releases on behalf of its clients. Postmedia…

The Annual Meeting of the International Society of Microbiota will be organized in Venice, Italy with a workshop dedicated to microbiota business: From research to market

[ad_1] image: October 17th will be dedicated to the ISM Workshop 2023: Microbiota Business: From Research to Market. view more  Credit: Credits to the International Society of Microbiota (ISM). The 10th…